JPS6358839B2 - - Google Patents

Info

Publication number
JPS6358839B2
JPS6358839B2 JP56098113A JP9811381A JPS6358839B2 JP S6358839 B2 JPS6358839 B2 JP S6358839B2 JP 56098113 A JP56098113 A JP 56098113A JP 9811381 A JP9811381 A JP 9811381A JP S6358839 B2 JPS6358839 B2 JP S6358839B2
Authority
JP
Japan
Prior art keywords
water
echinoside
methanol
sea cucumber
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56098113A
Other languages
Japanese (ja)
Other versions
JPS57212200A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP56098113A priority Critical patent/JPS57212200A/en
Publication of JPS57212200A publication Critical patent/JPS57212200A/en
Publication of JPS6358839B2 publication Critical patent/JPS6358839B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は抗真菌剤などとして有用なエキノサイ
ドAの新規製造法に関する。 エキノサイド(Echinoside)Aは特願昭54−
160181号に記載されているとおり、ナマコ類
(Holothuroidea)のアクチノピーガ
(Actinopyga)属に属するアクチノピーガ・エキ
ニーテス(Actinopyga echinites JAEGER)か
ら単離された抗真菌活性を有するオリゴ配糖体で
あり、次の構造式で表わされる。 エキノサイドAの性状は次のとおりである。 (1) 分子式(分子量) C54H87O26SNa(1206) (2) 元素分析 C54H87O26SNa・2H2Oとして 計算値 C52.16;H7.38;S2.58 実験値 C52.41;H7.37;S2.42 (3) 融点 228〜230℃(80%EtOH) (4) 〔α〕12 D−6.0゜(pyridine、C=1.36) (5) 210nmより長波長には紫外吸収を示さない。 (6) IR(KBr、cm-1) 3380(vs*)、2940(s)、
2850(sh)、1760(sh)、1745(s)、1635(s)、
1460(s)、1385(s)、1260(s)、1070(s)、
945(w)、895(w)、820(w)、780(w) *vs 非常に強い s 強い m 中程度 w 弱い (7) CHCl3、アセトンに溶けない。 メタノール、エタノール、水に溶けにくい。 含水メタノール、含水エタノールに溶ける。 DMSO、ピリジンによく溶ける。 (8) 呈色反応(TLC) 発色試薬 Ehrlich……negative B.C.G.……negative Anthrone……青 2,4−DNP……橙 1%Ce(SO42・10%H2SO4……赤紫色 potassium rhodizonate test……陽性(オレ
ンジ) (9) 臭いはなく中性物質である。 (10) 無色針状晶である。 (11) CD(MeOH、c=0.196)、〔θ〕2480、〔θ〕223
−4000(neg、max)、〔θ〕2160、〔θ〕212+4500
(end absorption) (12) Rf 0.08 TLC Kieselgel 60F254 展開溶媒 CHCl3−MeOH−H2O=65:
35:10(下層) 本発明者らはさらに研究を重ねた結果、アクチ
ノピーガ属とは異なるボハドシア(Bohadschia)
属のクロテナマコ(Bohadschia graeffei SEM
PER)を用いてエキノサイドAを極めて高収率
で抽出することに成功し、これに基づいて本発明
を完成した。 すなわち本発明は、クロテナマコの体壁を溶媒
抽出することを特徴とするエキノサイドAの製造
法である。 溶媒抽出はエキノサイドAを溶解し得る水およ
び/または親水性有機溶媒、たとえば低級アルコ
ール(例、メタノール、エタノール、プロパノー
ル)、アセトンなどを用いて抽出することにより
行われる。溶媒の使用量はクロテナマコの体壁1
Kgに対して、たとえばメタノールの場合、通常約
1〜5程度である。有機溶媒による抽出は含水
状態で行うのが望ましいが、通常ナマコ体壁中に
含まれる水分でこの役割を果すことができる。抽
出は一般に熱抽出が効率良く、通常溶媒の沸点ま
たはそれ以下の温度で行われ、とりわけ還流下に
行うのが好都合である。 抽出液は減圧下に濃縮し、その残渣を水および
水と混らずエキノサイドAを溶解し得る有機溶媒
(例、ブタノール)の混液で分配する。混液中の
水と非水溶性有機溶媒の比率は、通常約1:1で
差し支えないが、必要により適宜調整し得る。 上記分配によつて得られる有機溶媒層を減圧下
に濃縮した後、その残渣を精製することによつて
エキノサイドAが高収率で得られる。精製法とし
ては、たとえば再結晶、カラムクロマトグラフイ
ーなどがあげられる。再結晶による精製は、まず
上記濃縮残渣をエキノサイドAを溶解し難い適当
な溶媒またはその混液で洗浄することによつて可
溶性部分を除き、ついで通常の再結晶操作を行う
のが望ましい。洗浄液としては、たとえばクロロ
ホルム−メタノール−水の混液が好都合に用いら
れる。混液は通常容量比で水1に対してクロロホ
ルム3〜5、メタノール10〜20程度の割合で調製
される。洗浄は室温もしくは冷却下で撹拌しなが
ら実施するのが好ましい。洗浄後は通常過によ
つて不溶部(エキノサイドA)を採取し、再結晶
操作に付す。再結晶溶媒としては、たとえばクロ
ロホルム−メタノール−水の混液や含水メタノー
ル、含水エタノール、含水アセトニトリルなどが
あげられる。上記混液を用いる場合、その配合割
合(容量比)は、通常水1に対してクロロホルム
1〜3、メタノール4〜8程度が望ましい。再結
晶操作は常法に従つて実施することができる。 本発明方法によれば、上記のような溶媒操作の
みでも高収率でエキノサイドAを結晶状で製造す
ることができ、工業的にも極めて有利である。本
方法ににおける好ましい実施態様としては、たと
えばクロテナマコの体壁をメタノールで熱抽出
し、抽出液の濃縮残渣を水−ブタノールで分配
後、ブタノール層を濃縮し、その残渣をクロロホ
ルム−メタノール−水の混液で精製してエキノサ
イドAを結晶化するエキノサイドAの製造法があ
げられる。 本方法によつて製造されるエキノサイドAは優
れた抗真菌作用を有し、その抗菌スペクトルも広
いので、抗真菌剤、たとえば抗カビ剤、抗白癬菌
剤、抗カンジダ菌剤などとして、白癬症(例、水
虫など)やカンジダ症などの治療・予防に有用で
ある。 エキノサイドAは毒性が低いので、上記用途に
経口的に用いることもできるが、通常は外用剤と
して非経口的に用いるのが望ましい。かかる外用
の抗真菌剤として用いる場合、エキノサイドAを
微粉末状でそのまま適用するかまたはエキノサイ
ドAを含有する抽出エキスの状態で適用してもよ
いが、通常は適当な担体とともに医薬組成物の形
で使用するのが望ましい。 抗真菌剤としての医薬組成物は、たとえばエキ
ノサイドAを適当な液体担体(たとえば溶剤)に
溶解するか、あるいはこれに分散させ、または適
当な固体担体(たとえば希釈剤、増量剤)と混合
するか、あるいはこれに吸着させ、必要な場合に
はさらにこれらに、適当な添加剤、たとえば乳化
剤、分散剤、懸濁剤、展着剤、浸透剤、湿潤剤、
粘漿剤、安定剤などを添加して、たとえば溶液
剤、顆粒剤、乳剤、懸濁剤、軟膏剤、散剤、噴霧
剤、パスター剤、パツプ剤などを剤型とすること
ができる。 液体担体としては、具体的には例えば水、アル
コール類(たとえばメチルアルコール、エチルア
ルコール、グリコール、グリセリンなど)、グリ
コールエーテル類(たとえばエチレングリコール
モノメチルエーテル、ジエチレングリコールモノ
メチルエーテルなど)等に用いられる。固体担体
としては具体的には、例えばワツクス類(たとえ
ばポリエチレングリコール4000、鯨蝋、木蝋な
ど)等が挙げられる。 抗真菌剤中における有効成分量は、限定される
べきものではないが、たとえば水虫治療の目的で
用いる場合、通常は製剤全体に対してエキノサイ
ドA約0.01〜70重量%、より好ましくは約0.1〜
5重量%である。又、本発明における抗真菌剤は
公知の他の抗真菌剤と同様、たとえばサリチル酸
などの角質溶解剤、たとえばウンデシレン酸、グ
リセオフルビン、フエザチオン等の他の抗菌剤、
たとえばペニシリン類、セフアロスポリン類、ス
トレプトマイシン、フラジオマイシン、テトラサ
イクリン等の他の抗生物質をさらに含んでいても
よい。 上記の抗真菌剤は常法に従つて1日1〜数回患
部に塗布、噴霧などの手段で適用される。 以下に、試験例および実施例によつて本発明を
さらに詳細に説明するが、本発明の範囲がこれら
に限定されるものではない。 試験例 エキノサイドAの抗菌力試験 寒天培地による倍数希釈法を用いエキノサイド
Aの下記試験菌に対する最少生育阻止濃度を求め
た。検定培地は1%グルコース・ブイヨン寒天培
地(PH6.0)で、試験化合物をメタノールに溶解
後、殺菌水で希釈して用いた。培地中の濃度は1/
10になる様調整した。各試験菌は菌液塗抹接種法
を用い、培養は28℃、3日間行なつた。 試験結果を表1に示す。
The present invention relates to a new method for producing Echinoside A, which is useful as an antifungal agent. Echinoside A is a patent application filed in 1982.
As described in No. 160181, it is an oligoglycoside with antifungal activity isolated from Actinopyga echinites JAEGER, which belongs to the genus Actinopyga of the sea cucumber (Holothuroidea), and has the following structure. It is expressed by the formula. The properties of Echinocide A are as follows. (1) Molecular formula (molecular weight) C 54 H 87 O 26 SNa (1206) (2) Elemental analysis C 54 H 87 O 26 SNa・2H 2 O Calculated value C52.16; H7.38; S2.58 Experimental value C52 .41; H7.37; S2.42 (3) Melting point 228-230°C (80% EtOH) (4) [α] 12 D −6.0° (pyridine, C=1.36) (5) For wavelengths longer than 210 nm Does not exhibit ultraviolet absorption. (6) IR (KBr, cm -1 ) 3380 (vs * ), 2940 (s),
2850 (sh), 1760 (sh), 1745 (s), 1635 (s),
1460(s), 1385(s), 1260(s), 1070(s),
945 (w), 895 (w), 820 (w), 780 (w) *vs Very strong s Strong m Moderate w Weak (7) CHCl 3 , not soluble in acetone. Poorly soluble in methanol, ethanol, and water. Soluble in aqueous methanol and aqueous ethanol. Soluble in DMSO and pyridine. (8) Color reaction (TLC) Color reagent Ehrlich...negative BCG...negative Anthrone...blue 2,4-DNP...orange 1%Ce (SO 4 ) 2・10%H 2 SO 4 ...reddish-purple potassium rhodizonate test...Positive (orange) (9) It has no odor and is a neutral substance. (10) Colorless needle crystals. (11) CD (MeOH, c=0.196), [θ] 248 0, [θ] 223
-4000 (neg, max), [θ] 216 0, [θ] 212 +4500
(end absorption) (12) Rf 0.08 TLC Kieselgel 60F 254 developing solvent CHCl 3 −MeOH−H 2 O=65:
35:10 (lower layer) As a result of further research, the present inventors found that Bohadschia, which is different from the genus Actinopiga,
Genus Bohadschia graeffei SEM
We succeeded in extracting echinoside A at an extremely high yield using PER), and based on this, we completed the present invention. That is, the present invention is a method for producing echinocide A, which is characterized by extracting the body wall of the sea cucumber with a solvent. Solvent extraction is performed using water and/or a hydrophilic organic solvent that can dissolve Echinoside A, such as lower alcohols (eg, methanol, ethanol, propanol), acetone, and the like. The amount of solvent used is 1 part of the body wall of the sea cucumber.
For example, in the case of methanol, it is usually about 1 to 5 kg. It is preferable to perform extraction with an organic solvent in a water-containing state, but the water normally contained in the sea cucumber body wall can fulfill this role. Extraction is generally carried out efficiently by thermal extraction, usually at a temperature at or below the boiling point of the solvent, particularly conveniently carried out under reflux. The extract is concentrated under reduced pressure and the residue is partitioned with a mixture of water and an organic solvent (eg, butanol) that is immiscible with water and capable of dissolving Echinoside A. The ratio of water and water-insoluble organic solvent in the mixed solution is usually about 1:1, but can be adjusted as necessary. Echinoside A can be obtained in high yield by concentrating the organic solvent layer obtained by the above distribution under reduced pressure and then purifying the residue. Examples of purification methods include recrystallization and column chromatography. For purification by recrystallization, it is preferable to first remove the soluble portion by washing the concentrated residue with a suitable solvent or a mixture thereof in which Echinoside A is difficult to dissolve, and then perform a normal recrystallization operation. As the cleaning liquid, for example, a mixture of chloroform-methanol-water is conveniently used. The mixed solution is usually prepared in a volume ratio of 1 part water to 3 to 5 parts chloroform and 10 to 20 parts methanol. The washing is preferably carried out at room temperature or under cooling with stirring. After washing, the insoluble part (echinoside A) is collected by ordinary filtration and subjected to recrystallization. Examples of the recrystallization solvent include a mixture of chloroform-methanol-water, aqueous methanol, aqueous ethanol, and aqueous acetonitrile. When using the above-mentioned liquid mixture, the mixing ratio (volume ratio) is usually about 1 to 3 chloroform and 4 to 8 methanol to 1 part water. The recrystallization operation can be carried out according to a conventional method. According to the method of the present invention, echinoside A can be produced in crystalline form in a high yield simply by the above-mentioned solvent manipulation, and is extremely advantageous from an industrial standpoint. In a preferred embodiment of this method, for example, the body wall of a sea cucumber is thermally extracted with methanol, the concentrated residue of the extract is distributed between water and butanol, the butanol layer is concentrated, and the residue is mixed with chloroform, methanol, and water. There is a method for producing echinoside A in which echinoside A is crystallized by purification using a mixed solution. Echinoside A produced by this method has an excellent antifungal effect and has a broad antibacterial spectrum, so it can be used as an antifungal agent, such as an antifungal agent, an antitinea fungus agent, and an anticandida agent. It is useful for treating and preventing conditions such as athlete's foot (for example, athlete's foot) and candidiasis. Since Echinoside A has low toxicity, it can be used orally for the above purposes, but it is usually preferable to use it parenterally as an external preparation. When used as such an antifungal agent for external use, Echinoside A may be applied directly in the form of a fine powder or in the form of an extract containing Echinoside A, but it is usually applied in the form of a pharmaceutical composition with an appropriate carrier. It is preferable to use it in Pharmaceutical compositions as antifungal agents can be prepared, for example, by dissolving or dispersing Echinoside A in a suitable liquid carrier (e.g. a solvent) or by mixing it with a suitable solid carrier (e.g. diluent, filler). , or adsorbed thereto, and if necessary, further admixed with suitable additives such as emulsifiers, dispersants, suspending agents, spreading agents, penetrating agents, wetting agents, etc.
By adding mucilage agents, stabilizers, etc., the formulation can be made into solutions, granules, emulsions, suspensions, ointments, powders, sprays, pastes, poultices, etc. Specific examples of liquid carriers used include water, alcohols (eg, methyl alcohol, ethyl alcohol, glycol, glycerin, etc.), glycol ethers (eg, ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, etc.), and the like. Specific examples of solid carriers include waxes (eg, polyethylene glycol 4000, spermaceti, wax, etc.). The amount of active ingredient in the antifungal agent is not limited, but when used for the purpose of treating athlete's foot, it is usually about 0.01 to 70% by weight of Echinoside A, more preferably about 0.1 to 70% by weight, based on the entire preparation.
It is 5% by weight. In addition, the antifungal agent in the present invention is similar to other known antifungal agents, such as keratolytic agents such as salicylic acid, other antibacterial agents such as undecylenic acid, griseofulvin, fuezathion, etc.
Other antibiotics such as penicillins, cephalosporins, streptomycin, fradiomycin, and tetracyclines may also be included. The above-mentioned antifungal agents are applied to the affected area once to several times a day in accordance with conventional methods, such as by coating or spraying. The present invention will be explained in more detail below using test examples and examples, but the scope of the present invention is not limited thereto. Test Example Antibacterial activity test of Echinocide A The minimum growth-inhibiting concentration of Echinocide A against the following test bacteria was determined using the multiple dilution method using an agar medium. The assay medium was a 1% glucose bouillon agar medium (PH6.0), and the test compound was dissolved in methanol and then diluted with sterilized water. The concentration in the medium is 1/
I adjusted it to be 10. Each test bacterium was cultured at 28°C for 3 days using the bacterial liquid smear inoculation method. The test results are shown in Table 1.

【表】【table】

【表】 実施例 エキノサイドAの製造 クロテナマコBohadschia graeffei(SEM
PER)の体壁120匹(14Kg)を細かく切断した
後、メタノール(20)で熱抽出(3回)する。
メタノールを減圧濃縮し得られる残渣(70g)
を、水−ブタノール(約10−約10)で分配す
る。ブタノール層を減圧濃縮し得られる残渣
(230g)にクロロホルム(400ml)、メタノール
(1500ml)、水(100ml)を加え、室温(15℃)で
24時間撹拌した後、過し不溶部(130g)を得
る。不溶部6gをクロロホルム(80ml)−メタノ
ール(240ml)−水(40ml)から再結晶しエキノサ
イドA5g(45%from n−BuOH ext.)を得る。 上記クロテナマコより得られたエキノサイドA
は、Actinopyga echinites(Jaeger)より得ら
れている標品のエキノサイドAと混融、〔α〕D
13CNMRにより同定した。
[Table] Example Production of Echinocide A Black sea cucumber Bohadschia graeffei (SEM
After cutting the body walls of 120 (14 kg) PER) into small pieces, they were heat-extracted (3 times) with methanol (20).
Residue obtained by concentrating methanol under reduced pressure (70g)
Partition water-butanol (ca. 10-ca. 10). The butanol layer was concentrated under reduced pressure, and chloroform (400 ml), methanol (1500 ml), and water (100 ml) were added to the resulting residue (230 g), and the mixture was heated at room temperature (15°C).
After stirring for 24 hours, filter the insoluble portion (130 g). 6 g of the insoluble portion was recrystallized from chloroform (80 ml) - methanol (240 ml) - water (40 ml) to obtain 5 g of echinoside A (45% from n-BuOH ext.). Echinocide A obtained from the above sea cucumber
is mixed with standard echinocide A obtained from Actinopyga echinites (Jaeger), [α] D ,
13 Identified by CNMR.

Claims (1)

【特許請求の範囲】 1 クロテナマコの体壁を溶媒抽出することを特
徴とするエキノサイドAの製造法。 2 特許請求の範囲第1項記載の方法において、
クロテナマコの体壁を親水性有機溶媒で抽出し、
抽出物を水−非水溶性有機溶媒で分配後、有機溶
媒層からエキノサイドAを結晶化させるエキノサ
イドAの製造法。 3 特許請求の範囲第1項記載の方法において、
クロテナマコの体壁のメタノールで熱抽出し、抽
出液の濃縮残渣を水−ブタノールで分配後、ブタ
ノール層を濃縮し、その残渣をクロロホルム−メ
タノール−水の混液で精製してエキノサイドAを
結晶化させるエキノサイドAの製造法。
[Claims] 1. A method for producing echinocide A, which comprises extracting the body wall of a sea cucumber with a solvent. 2. In the method described in claim 1,
Extract the body wall of the sea cucumber with a hydrophilic organic solvent,
A method for producing echinoside A, which comprises distributing the extract between water and a water-insoluble organic solvent, and then crystallizing echinoside A from the organic solvent layer. 3. In the method described in claim 1,
The body wall of the sea cucumber is thermally extracted with methanol, the concentrated residue of the extract is distributed between water and butanol, the butanol layer is concentrated, and the residue is purified with a mixture of chloroform, methanol, and water to crystallize echinoside A. Method for producing echinocide A.
JP56098113A 1981-06-23 1981-06-23 Preparation of echinoside a Granted JPS57212200A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56098113A JPS57212200A (en) 1981-06-23 1981-06-23 Preparation of echinoside a

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56098113A JPS57212200A (en) 1981-06-23 1981-06-23 Preparation of echinoside a

Publications (2)

Publication Number Publication Date
JPS57212200A JPS57212200A (en) 1982-12-27
JPS6358839B2 true JPS6358839B2 (en) 1988-11-17

Family

ID=14211260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56098113A Granted JPS57212200A (en) 1981-06-23 1981-06-23 Preparation of echinoside a

Country Status (1)

Country Link
JP (1) JPS57212200A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004517172A (en) * 2001-03-30 2004-06-10 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ Natural fluorescent dyes obtained from marine invertebrates, compositions containing said dyes, and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629623A (en) * 1984-06-11 1986-12-16 Biomatrix, Inc. Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof
AU684828B2 (en) * 1993-08-19 1998-01-08 Merck Sharp & Dohme Corp. Thermodynamically stable crystal form of 4"-deoxy-4"-(epi)-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
US6055936A (en) * 1997-01-21 2000-05-02 Collin; Peter Donald Sea cucumber carotenoid lipid fractions and process
AU2003300712A1 (en) * 2003-12-31 2005-07-21 Council Of Scientific And Industrial Research Isolation of bivittoside d from sea cucumber and activity thereof
CN106636286B (en) * 2016-12-28 2021-07-27 中国海洋大学 Desugarized sea cucumber secondary saponin and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004517172A (en) * 2001-03-30 2004-06-10 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ Natural fluorescent dyes obtained from marine invertebrates, compositions containing said dyes, and uses thereof

Also Published As

Publication number Publication date
JPS57212200A (en) 1982-12-27

Similar Documents

Publication Publication Date Title
JPS6123192B2 (en)
Petroski et al. Isolation, semi-synthesis, and NMR spectral studies of loline alkaloids
DD271705A5 (en) METHOD FOR PRODUCING AZITHROMYCINE DIHYDRATE
US3945993A (en) Derivatives of polyene macrolide antibiotics
JPS6358839B2 (en)
US4035568A (en) Derivatives of polyene macrolide antibiotics
DE2651773C3 (en) 14-Acyloxy-daunorubicins, processes for their preparation and pharmaceutical compositions containing these compounds
CA1124235A (en) Method for preparing new 1,8-dihydroxy-10-acyl-9- anthrones for the treatment of psoriasis
DE1643835B2 (en) 21-ALDEHYDE OF THE PREGN SERIES AND ITS DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THESE
JPS6245880B2 (en)
DE2221939C3 (en) 2- (3-Pyridazinyl) -3- (4-methylpiperazino-carbonyloxy) -1-isoindolinone derivatives, processes for their preparation and pharmaceutical compositions containing them
JPH0368880B2 (en)
Dale PREPARATION OF BROMOACETYLGLUCOSE AND CERTAIN OTHER BROMOACETYL SUGARS.
US2161114A (en) Soluble double salts of theophylline and monoamino polyhydric alcohols
DE2632115A1 (en) NEW SEROTONE DERIVATIVES, PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEM
JP3053205B2 (en) Chemical derivatives of the antibiotic LL-E19020 alpha and beta
DE1770351C2 (en) 2-0-Acyl-clindamycins, processes for their preparation and antibiotic preparations containing these compounds
DE1695849A1 (en) Process for the preparation of new pyrimidine derivatives
IL22583A (en) Pilocarpine benzoate
EP0175264B1 (en) Process for the preparation of 2-amino-3-cyano-5-dialkoxymethyl pyrazines and intermediates for this process
JPS5821601B2 (en) Shinkidioxan Yudoutai Oyobi Sonoseizouhou Narabini Youto
JPS6219598A (en) 2,3,2'3'-tetra-o-alkyl-alpha,alpha-trehalose derivative
DE3317159C2 (en)
EP0181409A1 (en) 15(r+s)-fluorine-11,15-didesoxyprostaglandin e 1? derivatives
DE2230031A1 (en) Chlorhexidine salts and processes for their preparation